+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency Rooms, Intensive Care Units), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 85 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893230
The global critical care diagnostics market size is expected to reach USD 1.72 billion by 2030. The market is expected to grow at a CAGR of 4.9% from 2023 to 2030. The key factors supporting the industry’s growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 5.5% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU’s. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights

  • The Asia Pacific region is expected to grow at the fastest CAGR of 6.9% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU’s, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Critical Care Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Critical Care Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Critical Care Diagnostics: Type Estimates & Trend Analysis
4.1. Critical Care Diagnostics Market: Key Takeaways
4.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Routine and Special Chemistry
4.3.1. Routine and special chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Flow Cytometry
4.4.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Hematology
4.5.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Immunoproteins
4.6.1. Immunoproteins market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Microbial and Infectious Disease
4.7.1. Microbial and infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Coagulation Testing
4.8.1. Coagulation testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Critical Care Diagnostics: End Use Estimates & Trend Analysis
5.1. Critical Care Diagnostics Market: Key Takeaways
5.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Operation Room
5.3.1. Operation room market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Intensive Care Unit
5.4.1. Intensive care unit market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Emergency Rooms
5.5.1. Emergency rooms market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Critical Care Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Critical Care Diagnostics Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Danaher
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. F. Hoffmann-La Roche Ltd
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. BD
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. EKF Diagnostics
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. bioMérieux, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Siemens Healthcare Private Limited
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Chembio Diagnostics, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Bayer AG
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 3 North America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 4 North America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 Canada critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 10 Europe critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 13 Germany critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 UK critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 France critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 17 France critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 19 Italy critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Spain critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Sweden critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 23 Sweden critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Norway critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 25 Norway critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Denmark critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 Japan critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 32 Japan critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 China critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 34 China critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 India critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 India critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 38 Australia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Thailand critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 40 Thailand critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 South Korea critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 42 South Korea critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 44 Latin America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 47 Brazil critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 Mexico critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 56 South Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 60 UAE critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Critical care diagnostics: Market outlook
Fig. 8 Critical care diagnostics: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Critical care diagnostics market driver impact
Fig. 14 Critical care diagnostics market restraint impact
Fig. 15 Critical care diagnostics market strategic initiatives analysis
Fig. 16 Critical care diagnostics market: Type movement analysis
Fig. 17 Critical care diagnostics market: Type outlook and key takeaways
Fig. 18 Routine and special chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Immunoproteins market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Microbial and infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Coagulation testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Critical care diagnostics market: End use movement analysis
Fig. 26 Critical care diagnostics market: End use outlook and key takeaways
Fig. 27 Operation room market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Intensive care unit market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Emergency rooms market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Global critical care diagnostics market: Regional movement analysis
Fig. 32 Global critical care diagnostics market: Regional outlook and key takeaways
Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • BD
  • EKF Diagnostics
  • bioMérieux, Inc.
  • Siemens Healthcare Private Limited
  • Chembio Diagnostics, Inc.
  • Bayer AG

Methodology

Loading
LOADING...

Table Information